Assessment of vitamin D in patients with obesity after COVID‑19

Feofanova Tatyana Borisovna, Zainudinov Zainudin Musaevich

The COVID-19 is an extremely serious public health issue. Currently, the most important approach to prevention is to strengthen the immune system. It has been shown that vitamin D can actively resist viral infection, determining the prognosis. Obesity limits exercise tolerance, leads to shortness of breath, and is a risk factor for cardiovascular complications. Thus, COVID-19 and obesity mutually aggravate each other, affecting the development of the disease and prognosis. Objective is to control the level of vitamin D in obese patients who have undergone COVID-19. The study included 39 overweight people who had COVID-19. An assessment of the cardiological status, laboratory tests were carried out. Vitamin D deficiency was detected in 100% of patients - the average level was 23.39±1.84 ng/ml. Comprehensive treatment (including correction of vitamin D deficiency) contributed to the improvement of nutritional status, correction of carbohydrate metabolism, antioxidant status, and cytoprotection. Thus, it is promising to control and correct vitamin D levels in obese patients during COVID-19 to improve the course of the disease and prognosis.

Keywords:COVID-19, vitamin D, obesity, immunity, rehabilitation.